1. Home
  2. YETI vs IDYA Comparison

YETI vs IDYA Comparison

Compare YETI & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo YETI Holdings Inc.

YETI

YETI Holdings Inc.

HOLD

Current Price

$51.09

Market Cap

3.8B

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$36.19

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YETI
IDYA
Founded
2006
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.5B
IPO Year
2016
2019

Fundamental Metrics

Financial Performance
Metric
YETI
IDYA
Price
$51.09
$36.19
Analyst Decision
Buy
Strong Buy
Analyst Count
12
16
Target Price
$47.75
$52.86
AVG Volume (30 Days)
999.7K
1.4M
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.90
EPS
0.13
N/A
Revenue
$1,868,494,000.00
$218,710,000.00
Revenue This Year
$9.07
N/A
Revenue Next Year
$7.11
$201.05
P/E Ratio
$392.23
N/A
Revenue Growth
2.11
3024.43
52 Week Low
$30.51
$21.33
52 Week High
$51.89
$40.58

Technical Indicators

Market Signals
Indicator
YETI
IDYA
Relative Strength Index (RSI) 60.11 55.03
Support Level $43.59 $29.51
Resistance Level N/A $38.17
Average True Range (ATR) 1.79 1.56
MACD -0.04 -0.40
Stochastic Oscillator 76.39 23.52

Price Performance

Historical Comparison
YETI
IDYA

About YETI YETI Holdings Inc.

YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: